FDA May Delay Approval of New Opioid Drugs
The Food and Drug Administration is asking for additional studies on the safety of a powerful new opioid medicine designed to treat constipation. The FDA's…
Nektar Therapeutics
Nektar Begins Testing of New Opioid Painkiller
Nektar Therapeutics (NASDAQ: NKTR) has announced positive results from an early study on the effectiveness of a new short-acting opioid drug candidate. The company said…
Nektar Begins Phase II Study of New Opioid
Nektar Therapeutics (NASDAQ: NKTR) has enrolled the first patient in a Phase II clinical study of a new opioid analgesic that is designed to enter…